CLINICAL_TRIALS ClinicalTrials.gov record update

A Phase Ib/II Open Label, Multi-arm, Parallel Cohort Dose Finding and Expansion Study to Assess the Safety, Pharmacokinetics and Efficacy of NUC-3373, a Nucleotide Analogue, Given in Combination With Standard Approved Agents in Patients With Advanced Solid Tumours

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT05714553
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-25T22:27:34.732343+00:00
Published At: 2025-07-18T00:00:00+00:00
Record Updated At: 2025-07-18
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Advanced Cancer", "Advanced Solid Tumor", "Neoplasm Malignant", "Metastatic Cancer", "Melanoma", "Classical Hodgkin Lymphoma", "Non Small Cell Lung Cancer", "Renal Cell Carcinoma", "Urothelial Carcinoma", "Head and Neck Squamous Cell Carcinoma", "Subungual Squamous Cell Carcinoma", "Oesophageal Carcinoma", "MSI-H Colorectal Cancer", "Gastric Cancer", "Triple Negative Breast Cancer", "Endometrial Carcinoma", "Pleural Mesothelioma"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2025-07-18"
protocolSection.identificationModule.nctId: "NCT05714553"
protocolSection.identificationModule.officialTitle: "A Phase Ib/II Open Label, Multi-arm, Parallel Cohort Dose Finding and Expansion Study to Assess the Safety, Pharmacokinetics and Efficacy of NUC-3373, a Nucleotide Analogue, Given in Combination With Standard Approved Agents in Patients With Advanced Solid Tumours"
protocolSection.statusModule.overallStatus: "TERMINATED"
protocolSection.designModule.phases: ["PHASE1", "PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.